Department of Anesthesiology, Medical Branch, University of Texas, 301 University Boulevard, Galveston, TX, 77555, USA.
Department of General Medicine, International University of Health and Welfare, Shioya Hospital, Tochigi, 329-2145, Japan.
Sci Rep. 2021 Dec 14;11(1):23966. doi: 10.1038/s41598-021-03320-w.
In sepsis, microvascular hyperpermeability caused by oxidative/nitrosative stress (O&NS) plays an important role in tissue edema leading to multi-organ dysfunctions and increased mortality. We hypothesized that a novel compound R-107, a modulator of O&NS, effectively ameliorates the severity of microvascular hyperpermeability and preserves multi-organ function in ovine sepsis model. Sepsis was induced in twenty-two adult female Merino sheep by intravenous infusion of Pseudomonas aeruginosa (PA) (1 × 10 CFUs). The animals were allocated into: 1) Control (n = 13): intramuscular injection (IM) of saline; and 2) Treatment (n = 9): IM of 50 mg/kg R-107. The treatment was given after the PA injection, and monitored for 24-h. R-107 treatment significantly reduced fluid requirement (15-24 h, P < 0.05), net fluid balance (9-24 h, P < 0.05), and water content in lung/heart/kidney (P = 0.02/0.04/0.01) compared to control. R-107 treatment significantly decreased lung injury score/modified sheep SOFA score at 24-h (P = 0.01/0.04), significantly lowered arterial lactate (21-24 h, P < 0.05), shed syndecan-1 (3-6 h, P < 0.05), interleukin-6 (6-12 h, P < 0.05) levels in plasma, and significantly attenuated lung tissue 3-nitrotyrosine and vascular endothelial growth factor-A expressions (P = 0.03/0.002) compared to control. There was no adverse effect in R-107 treatment. In conclusion, modulation of O&NS by R-107 reduced hyperpermeability markers and improved multi-organ function.
在脓毒症中,氧化/硝化应激(O&NS)引起的微血管通透性增加在导致多器官功能障碍和死亡率增加的组织水肿中起重要作用。我们假设一种新型化合物 R-107,一种 O&NS 的调节剂,可有效改善绵羊脓毒症模型中微血管通透性的严重程度并维持多器官功能。通过静脉内输注铜绿假单胞菌(PA)(1×10 CFUs)在 22 只成年雌性美利奴羊中诱导脓毒症。将动物分为:1)对照组(n=13):肌肉内注射(IM)生理盐水;和 2)治疗组(n=9):IM 注射 50mg/kg R-107。在 PA 注射后给予治疗,并监测 24 小时。与对照组相比,R-107 治疗显著减少液体需求(15-24 小时,P<0.05)、净液体平衡(9-24 小时,P<0.05)和肺/心脏/肾脏的水含量(P=0.02/0.04/0.01)。与对照组相比,R-107 治疗在 24 小时时显著降低肺损伤评分/改良绵羊 SOFA 评分(P=0.01/0.04),显著降低动脉乳酸(21-24 小时,P<0.05)、脱落的 syndecan-1(3-6 小时,P<0.05)、白细胞介素-6(6-12 小时,P<0.05)水平在血浆中,并显著降低肺组织 3-硝基酪氨酸和血管内皮生长因子-A 的表达(P=0.03/0.002)与对照组相比。R-107 治疗没有不良反应。总之,R-107 对 O&NS 的调节减少了通透性标志物并改善了多器官功能。